Apr 20: GSK buys Stiefel for $3.6bn

GlaxoSmithKline on Monday confirmed it was to acquire Stiefel Laboratories, a US maker of skin care pharmaceuticals, for up to $3.6bn. Andrew Jack, pharmaceuticals correspondent, talks to Daniel Garrahan about what the deal is designed to do and whether it is good value for GSK.